PLXNA4
Basic information
Region (hg38): 7:132123340-132648688
Previous symbols: [ "PLXNA4A", "PLXNA4B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXNA4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 115 | 16 | 132 | |||
missense | 134 | 10 | 152 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 23 | 4 | 27 | |||
non coding | 12 | 21 | ||||
Total | 0 | 0 | 141 | 137 | 27 |
Variants in PLXNA4
This is a list of pathogenic ClinVar variants found in the PLXNA4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-132130473-C-T | PLXNA4-related disorder | Likely benign (Aug 24, 2021) | ||
7-132130474-G-A | PLXNA4-related disorder | Likely benign (Mar 10, 2022) | ||
7-132130494-C-T | PLXNA4-related disorder | Uncertain significance (Dec 21, 2023) | ||
7-132130515-T-G | PLXNA4-related disorder | Likely benign (Dec 20, 2021) | ||
7-132130528-A-C | PLXNA4-related disorder | Uncertain significance (Feb 22, 2024) | ||
7-132130550-C-T | PLXNA4-related disorder | Uncertain significance (Sep 19, 2024) | ||
7-132130551-A-G | PLXNA4-related disorder | Benign (Jul 19, 2022) | ||
7-132130553-C-T | PLXNA4-related disorder | Uncertain significance (Dec 29, 2023) | ||
7-132130554-G-A | PLXNA4-related disorder | Likely benign (Jan 03, 2024) | ||
7-132130556-G-A | PLXNA4-related disorder | Benign (Apr 29, 2020) | ||
7-132130569-A-G | PLXNA4-related disorder | Likely benign (Apr 11, 2022) | ||
7-132130571-G-A | PLXNA4-related disorder | Uncertain significance (Feb 07, 2024) | ||
7-132130578-C-T | PLXNA4-related disorder | Likely benign (Apr 20, 2022) | ||
7-132130579-G-A | PLXNA4-related disorder | Likely benign (Sep 03, 2021) | ||
7-132130584-G-A | PLXNA4-related disorder | Benign (Jul 19, 2022) | ||
7-132133051-C-G | PLXNA4-related disorder | Uncertain significance (Mar 29, 2024) | ||
7-132133054-C-T | PLXNA4-related disorder | Uncertain significance (Jul 01, 2024) | ||
7-132133064-G-T | PLXNA4-related disorder | Likely benign (May 26, 2021) | ||
7-132133074-G-A | PLXNA4-related disorder | Likely benign (Sep 22, 2021) | ||
7-132133091-T-C | PLXNA4-related disorder | Benign (Jul 19, 2022) | ||
7-132133099-T-C | PLXNA4-related disorder | Uncertain significance (Dec 30, 2023) | ||
7-132133125-C-T | PLXNA4-related disorder | Uncertain significance (Jun 17, 2024) | ||
7-132133126-G-A | PLXNA4-related disorder | Uncertain significance (Feb 15, 2024) | ||
7-132133142-G-A | PLXNA4-related disorder | Likely benign (Jan 23, 2024) | ||
7-132133146-G-C | PLXNA4-related disorder | Uncertain significance (Dec 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLXNA4 | protein_coding | protein_coding | ENST00000359827 | 31 | 525357 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000119 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.80 | 788 | 1.15e+3 | 0.685 | 0.0000722 | 12422 |
Missense in Polyphen | 291 | 562.39 | 0.51744 | 6094 | ||
Synonymous | -2.89 | 568 | 487 | 1.17 | 0.0000331 | 3723 |
Loss of Function | 7.32 | 12 | 84.8 | 0.142 | 0.00000439 | 983 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Coreceptor for SEMA3A. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance in the developing nervous system. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin. The plexin modulates the affinity of the complex for specific semaphorins, and its cytoplasmic domain is required for the activation of down-stream signaling events in the cytoplasm (By similarity). {ECO:0000250}.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema3A PAK dependent Axon repulsion;Other semaphorin interactions;Semaphorin interactions;Axon guidance;CRMPs in Sema3A signaling
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.191
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.21
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.132
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plxna4
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- negative regulation of cell adhesion;regulation of cell shape;facial nerve structural organization;glossopharyngeal nerve morphogenesis;trigeminal nerve structural organization;vagus nerve morphogenesis;postganglionic parasympathetic fiber development;chemorepulsion of branchiomotor axon;anterior commissure morphogenesis;regulation of cell migration;regulation of GTPase activity;sympathetic nervous system development;regulation of axon extension involved in axon guidance;positive regulation of axonogenesis;regulation of negative chemotaxis;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance
- Cellular component
- semaphorin receptor complex;plasma membrane;integral component of plasma membrane
- Molecular function
- semaphorin receptor activity